ProShares Ultra Nasdaq Biotechnology company logo
ProShares Ultra Nasdaq Biotechnology logo

BIB Stock

Summary

Current Price
As of today, BIB price is $81.77, down -0.97% on
Current Price vs All-Time High
BIB price is currently -27.68% below its historical high of $113.06 set on
Dividend Yield
BIB current TTM dividend yield is 0.60%
Next Ex-Dividend
As of today, the next dividend for BIB has not been scheduled

Profile

ETF profile for ProShares Ultra Nasdaq Biotechnology (BIB)
MetricValue
NameProShares Ultra Nasdaq Biotechnology
Assets Under Management$84M
Expense Ratio1.19%
Asset ClassEquity
DomicileUS
Inception Date
Net Asset Value81K USD
Websiteproshares.com
Last Ex-Dividend Date
Next Ex-Dividend DateN/A

Top 30 Holdings

Chart

Add series to chart(max: 6)
Series
SUGGESTED SERIES
ProShares Ultra Nasdaq Biotechnology chart

Technical Indicators

BIB Technical Indicators
MetricDateValue
$81.77
$69.05
SMA 200 vs Price-15.56%
$83.11
SMA 50 vs Price+1.63%
1.53
$3.19
52.70
67.26%
45.43%

Dividends

BIB Dividends
MetricDateValue
$0.01
N/AN/A
0.60%
$0.49

Country Weights

BIB Country Weightings
CountryWeight
United States60.28%
Netherlands1.47%
United Kingdom1.26%
France1.00%
Ireland0.87%
Denmark0.81%
Germany0.56%
Canada0.41%
Switzerland0.28%
Singapore0.12%
Bermuda0.10%
Jersey0.07%
Iceland0.06%
Spain0.06%
Cayman Islands0.05%
China0.04%
Australia0.04%
Israel0.03%
Belgium0.02%
Taiwan (Province of China)0.01%

Sector Weights

BIB Sector Weightings
SectorWeight
Healthcare69.72%

FAQ

  • Does BIB pay dividends?

    Yes, the ProShares Ultra Nasdaq Biotechnology does pays dividends, with the most recent payment being $0.01 per share. The last ex-dividend date was on March 24, 2026, and the next ex-dividend date has not been announced yet

  • What stocks are in BIB?

    As of today, ProShares Ultra Nasdaq Biotechnology includes 267 holdings, with 258 of them being companies from 20 different countries and 1 sectors. The most weighted holdings are Net Other Assets (Liabilities) (30.15%), Gilead Sciences, Inc. (6.78%) and Amgen Inc. (6.34%)

  • What is the current assets under management for BIB?

    Assets under management of ProShares Ultra Nasdaq Biotechnology is $84M

  • What is BIB average volume?

    Average volume of ProShares Ultra Nasdaq Biotechnology is $10K

  • What is BIB expense ratio?

    Expense ratio of ProShares Ultra Nasdaq Biotechnology is 1.19%

  • What is BIB inception date?

    Inception date of ProShares Ultra Nasdaq Biotechnology is April 7, 2010

Data Sources & References

  1. BIB Official Website www.proshares.com/our-etfs/leveraged-and-inverse/bib
  2. BIB Profile on Yahoo Finance finance.yahoo.com/quote/BIB